Artiva Biotherapeutics, Inc. (ARTV) › Shareholders' EquityArtiva Biotherapeutics, Inc. (ARTV) — Shareholders' EquityAnnual figures by period end, from SEC filings.2022-12-31: -$140.70M2023-12-31: -$162.01M2024-12-31: $186.64M2025-12-31: $109.97M$109.97M2022-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$109.97M-41.1%2026-03-10Balance as of period end2024-12-31$186.64M—2026-03-10Balance as of period end2023-12-31-$162.01M—2026-03-10Balance as of period end2022-12-31-$140.70M—2025-03-24Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)